3-[(2-methoxy-2-oxoethyl)thio]butanoic acid | 911636-81-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 3-[(2-methoxy-2-oxoethyl)thio]butanoic acid
• 英文别名: 3-(2-methoxy-2-oxoethyl)sulfanylbutanoic acid
• CAS: 911636-81-2
• 化学式: C₇H₁₂O₄S
• 分子量: 192.236
• InChiKey: NTHYHAZEHRVFLV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  12
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  88.9
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-[(2-methoxy-2-oxoethyl)thio]butanoic acid 在 三乙胺 、 氯甲酸异丁酯 、 sodium azide 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 1.5h， 生成
  参考文献：
  名称：

  WO2006/104356

  摘要：

  公开号：
• 作为产物：
  描述：

  t-butyl 3-[(2-methoxy-2-oxoethyl)thio]butanoate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 6.0h， 以85%的产率得到3-[(2-methoxy-2-oxoethyl)thio]butanoic acid
  参考文献：
  名称：

  WO2006/104356

  摘要：

  公开号：

文献信息

• [EN] MORPHOLINO SUBSTITUTED BICYCLIC PYRIMIDINE UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS<br/>[FR] DÉRIVÉS URÉE OU CARBAMATE DE PYRIMIDINE BICYCLIQUE À SUBSTITUTION MORPHOLINO EN TANT QU'INHIBITEURS DE MTOR
  申请人：CELLZOME LTD

  公开号：WO2013050508A1

  公开（公告）日：2013-04-11

  The invention relates to compounds of formula (I) wherein m, o, Ra, Rb, R1 and T1 have the meaning as cited in the description and the claims. Said compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.

  该发明涉及式(I)的化合物，其中m、o、Ra、Rb、R1和T1的含义如描述和权利要求中所述。所述化合物可用作mTOR的抑制剂，用于治疗或预防与mTOR相关的疾病和紊乱。该发明还涉及包括所述化合物的药物组合物，以及制备此类化合物以及用作药物的用途。
• Dipeptidyl Peptidase-IV Inhibiting Compounds, Method Of Preparing The Same, And Pharmaceutical Compositions Containing The Same As An Active Agent
  申请人：Lee Chang-Seok

  公开号：US20080188471A1

  公开（公告）日：2008-08-07

  The present invention relates to novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV (DPP-IV), methods of preparing the same and pharmaceutical compositions containing the same as an active agent.

  本发明涉及一种新型化合物，表现出良好的抑制二肽基肽酶-IV（DPP-IV）活性，制备该化合物的方法以及含有该化合物作为活性剂的制药组合物。
• Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent
  申请人：LG Life Sciences, Ltd.

  公开号：US07879848B2

  公开（公告）日：2011-02-01

  Novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV(DPP-IV) include those of the following formula (1) or pharmaceutically acceptable salt thereof: wherein A is a substituted or unsubstituted 1,4,5,7-tetrahydro-pyrazolo[3,4-c]pyridine, 5,6 -dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazine, 4,5-dihydro-7H-isooxazolo[3,4-c]pyridine, 3,4 -dihydroisoquinoline, 5,8-dihydropyrido[3,4-d]pyrimidine, or 6,7 -dihydro[1,3]thiazolo[4,5,c]pyridine, and B is a substituted or unsubstituted piperidin-2-one, morpholin-3-one, oxazolidin-2-one, pyrrolidin-2-one, or 1,5-dihydro-pyrrol-2-one. Methods of preparing the novel inhibitory compounds of formula (1) and pharmaceutical compositions containing the same as an active agent are disclosed.

  具有良好的抑制二肽基肽酶-IV（DPP-IV）活性的新化合物包括以下公式（1）或其药学上可接受的盐：其中A是取代或未取代的1,4,5,7-四氢-吡唑并[3,4-c]吡啶，5,6-二氢-8H-[1,2,4]三唑并[4,3-a]吡嗪，4,5-二氢-7H-异噁唑并[3,4-c]吡啶，3,4-二氢异喹啉，5,8-二氢吡啶并[3,4-d]嘧啶或6,7-二氢[1,3]噻唑并[4,5,c]吡啶，而B是取代或未取代的哌啶-2-酮，吗啉-3-酮，噁唑烷-2-酮，吡咯烷-2-酮或1,5-二氢吡咯-2-酮。公开了制备公式（1）中的新抑制化合物及含有其作为活性剂的药物组合物的方法。
• MORPHOLINO SUBSTITUTED BICYCLIC PYRIMIDINE UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS
  申请人：CELLZOME LIMITED

  公开号：US20140288066A1

  公开（公告）日：2014-09-25

  The invention relates to compounds of formula (I) wherein m, o, R a , R b , R 1 and T 1 have the meaning as cited in the description and the claims. The compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including the compounds, the preparation of the compounds as well as their use as medicaments.

  本发明涉及式（I）化合物，其中m，o，Ra，Rb，R1和T1的含义如说明书和权利要求所述。该化合物可用作mTOR的抑制剂，用于治疗或预防与mTOR相关的疾病和障碍。本发明还涉及包括该化合物的制药组合物、该化合物的制备以及其作为药物的用途。
• DIPEPTIDYL PEPTIDASE-IV INHIBITING COMPOUNDS, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT
  申请人：LG Life Sciences Ltd.

  公开号：EP1863812B1

  公开（公告）日：2010-07-14